Naunyn-Schmiedeberg s Archives of Pharmacology

作者应查阅Springer关于生成式AI图像的政策，并确保其工作符合该政策所述原则。 模型中文摘要

Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top

作者身份应仅限于在构思设计研究、开展研究、分析数据、贡献新方法或模型、撰写论文等方面做出实质性贡献的人员；所有投稿均通过iThenticate查重，涉嫌抄袭者将不经同行评审立即拒稿，且稿件必须严格遵守《作者须知》的形式要求，否则将被行政拒稿。 模型中文摘要

Authorship should incorporate and should be restricted to those who have contributed substantially to the work in one or more of the following categories: • Conceived of or designed study • Performed research • Analyzed data • Contributed new methods or models • Wrote the paper All submissions are checked via the plagiarism detection software iThenticate. Submissions suspected of any kind of plagi…

所有作者均需酌情提供资金来源、财务或非财务利益、伦理委员会批准、知情同意及动物福利声明等信息。 模型中文摘要

All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …

所有原创研究必须包含数据可用性声明，说明如何获取支持结果与分析的数据；若无法公开共享数据，则应说明数据获取方式及复用条件。 模型中文摘要

All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…

作者应在“Compliance with Ethical Standards”部分酌情披露资金来源、潜在利益冲突、知情同意及动物福利等声明。 模型中文摘要

To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…

Open Choice文章无需转让版权，版权仍归作者所有，作者同意以知识共享许可发表。 模型中文摘要

Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top

欲了解在本刊以开放获取方式发表的相关费用、资助和许可信息，请访问开放获取出版页面。 模型中文摘要

To find out more about publishing your work Open Access in Naunyn-Schmiedeberg's Archives of Pharmacology, including information on fees, funding and licences, visit our Open access publishing page. Back to top

涉嫌任何形式抄袭的投稿将不经同行评审立即拒稿。 模型中文摘要

Submissions suspected of any kind of plagiarism will be rejected immediately without further peer-review.

临床试验须按WHO定义进行前瞻性注册，即前瞻性地将人类参与者分配至健康相关干预组以评估健康结局。 模型中文摘要

The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…